Company intelligence / Profile preview

HERMES ARZNEIMITTEL

Pullach im Isartal, Bavaria, Germany
Ownership
Private
Employees
~150
Development stage
Other
01

Overview

HERMES ARZNEIMITTEL is a German pharmaceutical and consumer health company focused on self-medication and over-the-counter healthcare products. The company develops, manufactures, and markets a broad portfolio of branded OTC medicines, dietary supplements, dermopharmaceutical products, and selected medical devices, with flagship brands including Biolectra, doc, Aspecton, algovir, Betaisodona, and ANTI BRUMM. It is part of the privately held HERMES Group and operates primarily from Pullach, Germany, with additional presence in Austria and export partnerships across multiple international markets. The business is commercial-stage rather than pipeline-driven, with strong emphasis on brand management, pharmacy channel distribution, and everyday health categories such as musculoskeletal health, respiratory care, wound care, and prevention. HERMES ARZNEIMITTEL is best characterized as an established OTC pharma company rather than a biotech innovator.

Therapeutic areas
HematologyImmunologyOtherEndocrinologyCardiovascularNeurologyDermatologyInfectious DiseasesRheumatologyPulmonology
Modalities
Small moleculeBiologicDevicePhytopharmaceutical
Industry
Biotech
02

Partnerships

BetaisodonaANTI BRUMMOMRONExport distribution partners in approximately 25 countries

Beyond the preview

Go deeper on HERMES ARZNEIMITTEL.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on HERMES ARZNEIMITTEL.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call